Physician profile
Mario Gioia
NPI 1285098830
$2,864.98
in general payments reported to CMS, 2019-2025
23 companies · $57.04 in 2025
The $57.04 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $340 · 2021: $748 · 2022: $1,055 · 2023: $470 · 2024: $93.66 · 2025: $57.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $387.98 | 2020-2021 | |
| Abbott Laboratories | $351.91 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $318.82 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $313.75 | 2022-2023 | |
| Abiomed | $277.87 | 2020-2022 | |
| Pfizer INC. | $215.35 | 2021-2023 | |
| Amgen INC. | $171.62 | 2020-2023 | Repatha |
| Merck Sharp & Dohme LLC | $146.33 | 2019-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.60 | 2021-2023 | Jardiance |
| Irhythm Technologies, INC. | $115.73 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $72.21 | 2021-2022 | |
| Chiesi USA, INC. | $57.99 | 2021-2022 | |
| Edwards Lifesciences Corporation | $46.57 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $43.59 | 2021-2023 | Eliquis |
| Impulse Dynamics (USA) INC. | $41.73 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $41.08 | 2022-2023 | Onpattro |
| Baxter Healthcare | $35.07 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $33.19 | 2022 | |
| Allergan, INC. | $19.71 | 2019 | |
| United Therapeutics Corporation | $14.88 | 2021 | |
| Medivance, INC. | $14.13 | 2020 | |
| Novo Nordisk INC | $13.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Gioia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.